|
FMT-Female match |
FMT-Male match |
|
Transsexuals (n=29) |
DETECT (n=72) |
|
Transsexuals (n=21) |
DETECT (n=44) |
|
|
mean |
SD |
mean |
SD |
p |
mean |
SD |
mean |
SD |
p |
Age |
34.7 |
7.5 |
31.8 |
7.5 |
0.074 |
35.7 |
8.3 |
34.4 |
7.9 |
0.530 |
Age at diagnosis |
24.7 |
7.8 |
- |
- |
- |
24.7 |
7.8 |
- |
- |
- |
Length of HT |
4.9 |
4.6 |
- |
- |
- |
4.9 |
4.6 |
- |
- |
- |
Diseases |
n |
% |
n |
% |
p |
n |
% |
n |
% |
p |
Cardiovascular |
5 |
17.2 |
9 |
12.5 |
0.536 |
5 |
25.0 |
9 |
20.5 |
0.686 |
Respiratory |
5 |
17.2 |
7 |
9.7 |
0.299 |
3 |
15.0 |
5 |
11.4 |
0.687 |
Neurological |
1 |
3.5 |
10 |
13.9 |
0.162 |
0 |
0.0 |
4 |
9.1 |
- |
Endocrine |
5 |
17.2 |
34 |
47.2 |
0.008 |
2 |
10.0 |
17 |
38.6 |
0.033 |
Gastroenterological |
7 |
24.1 |
9 |
12.5 |
0.156 |
5 |
25.0 |
4 |
9.1 |
0.105 |
Urinary |
2 |
6.9 |
5 |
6.9 |
0.993 |
1 |
5.0 |
5 |
11.4 |
0.435 |
Tumoural |
2 |
6.9 |
8 |
11.1 |
0.527 |
1 |
5.0 |
1 |
2.3 |
0.574 |
Immune-mediated |
2 |
6.9 |
5 |
6.9 |
0.993 |
1 |
5.0 |
2 |
4.6 |
0.937 |
BMI (mean/SD) |
25.4 |
4.8 |
24.9 |
5.2 |
0.666 |
25.2 |
4.8 |
27.5 |
4.6 |
0.062 |
There is no indication of an increased risk associated with hormone treatment in transsexual patients. The values presented are means ± standard deviation (SD) or total
number (n) and percentage (%). Up to 3 controls were matched for each patient. Differences in the number of transsexual patients within the same row of the table are due
to differences in the availability of age-matched control subjects. FMT: female-to-male transsexuals; p: p-value. |